PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.\', \'Kondor Pharma Inc, Toronto, Canada.\', \'Internal Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences (TUMS), Tehran, Iran.\', \'Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences (TUMS), Tehran, Iran.\', \'Department of Neurology, School of Medicine, Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences (TUMS), Tehran, Iran.\', \'Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.\', \'Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medial Sciences (SBMU), Tehran, Iran.\', \'Clinical Trial Department, Behbalin Inc, Tehran, Iran.\', \'Department of Medical-Surgical Nursing and Basic Sciences, School of Nursing & Midwifery, Tehran University of Medical Sciences (TUMS), Tehran, Iran.\', \'Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran. saeed.karima@sbmu.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10787-022-00928-w
?:hasPublicationType
?:journal
  • Inflammopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 35201518
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.925
?:rankingScore_hIndex
  • 41
is ?:relation_isRelatedTo_publication of
?:title
  • Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all